Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Immunologic Deficiency Syndromes | Phase 4 | ClinicalTrials |
| Hepatitis; Hepatitis A | Phase 4 | ClinicalTrials |
| Immunologic Deficiency Syndromes | Phase 3 | ClinicalTrials |
| Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic | Early Phase 1 | ClinicalTrials |
| Immunologic Deficiency Syndromes | Phase 3 | ClinicalTrials |
| Pemphigoid, Bullous | Phase 2 | ClinicalTrials |
| Postpoliomyelitis Syndrome; Syndrome | Phase 2/Phase 3 | ClinicalTrials |
| Muscle Weakness; Myasthenia Gravis | Phase 4 | ClinicalTrials |
| Immunologic Deficiency Syndromes | Phase 3 | ClinicalTrials |
| Birth Weight; Infection | Phase 2/Phase 3 | ClinicalTrials |
| Neuritis; Peripheral Nervous System Diseases | Phase 3 | ClinicalTrials |
| Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia | Phase 3 | ClinicalTrials |
| Mucocutaneous Lymph Node Syndrome | Phase 3 | ClinicalTrials |
| Immunologic Deficiency Syndromes | Phase 3 | ClinicalTrials |
| Agammaglobulinemia | Phase 2 | ClinicalTrials |
| Postural Orthostatic Tachycardia Syndrome; Tachycardia | Phase 1/Phase 2 | ClinicalTrials |
| Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Sclerosis | Phase 3 | ClinicalTrials |
| Polyradiculoneuropathy; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Phase 3 | ClinicalTrials |
| Immunologic Deficiency Syndromes | Phase 2 | ClinicalTrials |
| Immunologic Deficiency Syndromes | Phase 3 | ClinicalTrials |
| Autoimmune Diseases; Autoimmune Diseases of the Nervous System; Encephalitis; Epilepsies, Partial; Epilepsy; Limbic Encephalitis; Nervous System Diseases; Seizures | Phase 2 | ClinicalTrials |
| Streptococcal Infections; Syndrome | Phase 4 | ClinicalTrials |
| Mucocutaneous Lymph Node Syndrome | Phase 3 | ClinicalTrials |
| Guillain-Barre Syndrome; Syndrome | Phase 3 | ClinicalTrials |
| Agammaglobulinemia; Common Variable Immunodeficiency; Hyper-IgM Immunodeficiency Syndrome; Hyper-IgM Immunodeficiency Syndrome, Type 1; Immunologic Deficiency Syndromes; Syndrome; Wiskott-Aldrich Syndrome | Phase 4 | ClinicalTrials |
| Deficiency Diseases; Immunologic Deficiency Syndromes | Phase 3 | ClinicalTrials |
| Pemphigoid, Bullous | Phase 3 | ClinicalTrials |
| Scleroderma, Diffuse; Scleroderma, Systemic; Sclerosis | Phase 2/Phase 3 | ClinicalTrials |
| Multiple Endocrine Neoplasia; Muscle Rigidity; Stiff-Person Syndrome; Syndrome | Phase 1 | ClinicalTrials |
| Polyneuropathies; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Phase 3 | ClinicalTrials |
| Cerebral Infarction; Ischemia; Stroke | Phase 1 | ClinicalTrials |
| Abortion, Habitual; Abortion, Spontaneous; Fetal Death | Phase 2 | ClinicalTrials |
| Cognitive Dysfunction | Phase 2 | ClinicalTrials |
| Lymphohistiocytosis, Hemophagocytic | Phase 3 | ClinicalTrials |
| Colonic Neoplasms; Melanoma; Urologic Neoplasms | Phase 2 | ClinicalTrials |
| Ataxia; Cerebellar Ataxia; Spinocerebellar Ataxias; Spinocerebellar Degenerations | Phase 2 | ClinicalTrials |
| Disease; Neuromyelitis Optica | Phase 2 | ClinicalTrials |
| Peripheral Nervous System Diseases | Phase 3 | ClinicalTrials |
| Neonatal Sepsis; Sepsis; Toxemia | Phase 3 | ClinicalTrials |
| Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia | Phase 3 | ClinicalTrials |
| Disease; Neuromyelitis Optica | Phase 2/Phase 3 | ClinicalTrials |
| Kidney Failure, Chronic | Phase 1 | ClinicalTrials |
| Viremia | Phase 1 | ClinicalTrials |
CONTENTS